Henderson Jane

Chief Financial OfficerApogee Therapeutics, Inc. (APGE) · full profile →Form 4 · filed May 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$164K
Net Open-Market Flow
-$164K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 1, 2026Sell(S)811$81.02$66K175K
May 1, 2026Sell(S)900$82.60$74K174K
May 1, 2026Sell(S)289$83.16$24K173K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-055091) within minutes of acceptance. Every field above traces to the original document. Verify it directly: